Drug Discovery & Research
Pancreatic Cancer Breakthrough: Experimental Combo Therapy Achieves 86% Survival Rate in Early Results
HealthAI Central Editorial Team·June 18, 2026·4 min read
Drug Discovery & Research
Pharma Giant Bets Half a Billion on Chip-Based Antibody Platform That Could Revolutionize Drug Hunting
HealthAI Central Editorial Team·June 17, 2026·4 min read
Drug Discovery & Research
Recursion Pharmaceuticals Advances Three AI-Discovered Drug Candidates Into Phase 2 Trials
Recursion Pharmaceuticals has announced that three drug candidates identified through its AI-powered drug discovery platform have advanced into Phase 2 clinical trials, marking a significant milestone for the AI-native pharmaceutical development model.
HealthAI Central Editorial Team·May 3, 2026·4 min read